RD-Connect webinars on data submission and analysis

The Lochmüller Lab submits genomic data to the RD-Connect Genome-Phenome Analysis Platform (GPAP) for diagnosis and gene discovery. This leading data sharing and analysis resource is also used by the European Solve-RD project for submission of data from the European Reference Networks for rare diseases. Solve-RD uses the RD-Connect Genome-Phenome Analysis Platform (GPAP) to allow submitters to analyse the exome and genome sequencing data of their rare disease patients. Phenotypic information (HPO-based) is collected using PhenoTips. The project is now organising two webinars to train clinicians, scientists and bioinformaticians from Solve-RD beneficiaries, associated partners and networks:

PhenoTips & data submission to GPAP
We will show how you can create PhenoTips entries and explain the different steps to submit your data to the RD-Connect Genome-Phenome Analysis Platform. There will be time to answer your questions.
Date: Wednesday, 16 January 2019, 12:00-13:00 CET
Trainer: Leslie Matalonga Borrell, Centro Nacional de Análisis Genómico, Barcelona, Spain
Registration: https://goo.gl/forms/DVKoqj3fiWOcHVpm1

Data analysis in GPAP
We will show how to use the RD-Connect Genome-Phenome Analysis Platform to analyse your data and explain the different functionalities and settings of the platform. There will be time to answer your questions.
Date: Friday, 18 January 2019, 12:00-13:00 CET
Trainer: Steven Laurie, Centro Nacional de Análisis Genómico, Barcelona, Spain
Registration: https://goo.gl/forms/i2OZCfTvf4j2adZm1

RD-Connect GPAP logo

Read next...

Sally describes lab research to FSHD visitors

Lochmüller Lab hosts information session on clinical research for FSHD

On Saturday June 11th we were delighted to welcome individuals and families living with facioscapulohumeral muscular dystrophy (FSHD) and members of the FSHD Society to...
JND-cover

May 2022 Issue of the Journal of Neuromuscular Diseases Available Online

The Lochmüller Lab is pleased to share that the the Journal of Neuromuscular Diseases has published its third issue of 2022! In Volume 9, Issue...
CHEO

CHEO Registers Tenth Patient in AMO Reach CDM Clinical Trial

The Lochmüller Lab is excited to share that as of March 14, 2022 our site at the Children’s Hospital of Eastern Ontario (CHEO) has registered...
CNDR_logo-2x3

Canadian Neuromuscular Disease Registry Launches New Congenital Myasthenic Syndrome Registry

We’re delighted to announce that a new registry for patients with congenital myasthenic syndrome (CMS) has just been launched within the Canadian Neuromuscular Disease Registry (CNDR).  This...
Lochmuller Lab at the Rideau Canal, group picture.

Lochmüller Lab Visits World’s Longest Skating Rink

This February the Lochmüller Lab took a break from the research benches at the CHEO RI to visit the Rideau Canal Skateway. A UNESCO world...
JND_V9-i1

January 2022 Issue of the Journal of Neuromuscular Diseases Available Online

The Lochmüller Lab is pleased to share that the the Journal of Neuromuscular Diseases has published its first issue of 2022! In Volume 9, Issue...